HD-OPM Archive
Topics › Plaque, CAC & CT angiography

JACC review: rapid plaque progression precedes rupture and LDL below 70 mg/dL halts it

Gokhan Can · Jan 02, 2026 · ♥ 19 reactions · 5 comments · original Facebook post
Plaque, CAC & CT angiographyLDL, ApoB & lipid panelHeart attack, stroke & procedures
AI summary & key facts

Summarises a 2019 JACC review arguing plaque progression is a necessary, modifiable step between subclinical atherosclerosis and MI, and that preventive strategy should shift toward imaging and aggressively treating subclinical disease. It reports data from PROSPECT, PARADIGM, GLAGOV and PESA showing progression stops at LDL <70 mg/dL and regression needs lower.

From Subclinical Disease to Rupture: The Role of Rapid Plaque Progression

#

This review from the Journal of the American College of Cardiology (from 2019) challenges the traditional understanding of acute coronary syndromes. It argues that plaque progression is a necessary, biologically distinct, and modifiable step linking subclinical atherosclerosis to plaque rupture and myocardial infarction (MI).

The authors propose a paradigm shift: moving away from preventing events based solely on population-derived risk estimates (primary prevention) toward preventing events by detecting subclinical atherosclerosis via imaging and treating it aggressively to halt progression.

  1. The Myth of the "Mild" Plaque

Historically, it was believed that most heart attacks resulted from the sudden rupture of mild, non-obstructive plaques. This was based on angiograms taken months or years before an event. However, the authors present evidence from serial imaging studies showing that these "mild" plaques undergo a phase of rapid progression shortly before rupturing.

  1. Redefining Plaque Progression

Progression should not be defined merely by luminal narrowing (stenosis) but by changes in plaque volume and composition (high-risk features). Computed Tomographic Angiography (CTA) studies highlight that plaques prone to rupture have specific quantitative features compared to stable plaques:

  1. Modifiability: The Role of LDL

The review asserts that plaque progression can be halted or reversed through intensive lipid-lowering therapy.

  1. A New Clinical Paradigm

The authors argue that the current distinction between "primary" and "secondary" prevention is outdated. Instead, patients should be stratified by the presence or absence of subclinical atherosclerosis detected via imaging (such as Calcium Scoring or CTA).

Conclusion

The authors conclude that identifying early, uncomplicated atherosclerosis offers a specific window of opportunity. By initiating intensive lipid-lowering therapy (Target LDL <70 mg/dl) upon detection, clinicians can halt the plaque progression necessary for rupture, effectively preventing acute coronary events before they occur.

Paper · Journal of the American College of Cardiology · 2019From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Eventsjacc.org

Research cited

#plaque#atherosclerosis#jacc#paradigm#statins#calcium#heartattack#prevention
← newer: SCOT-HEART: CT angiography cut 5-year coronary death or MI rolder: PCSK9 inhibitors regress plaque without the calcification su →